patients squamous cell cancer esophagus entered treatment protocol consisting preoperative chemotherapy ct surgical resection sr possible postoperative ct radiation therapy rt beginning august NUMBER ct consisted cycles NUMBER continuous intravenous infusion NUMBER days cisplatin NUMBER day NUMBER diuresis intervals postoperatively rt administered resection margins minimal paraesophageal nodes abnormal rt consisted NUMBER NUMBER cgy tumor area plus boost known abnormal tumor margins nineteen NUMBER patients resectable NUMBER sr death NUMBER NUMBER normal barium swallow visible tumor sr pathologic evidence residual disease complete radiologic gross clinical disappearance tumor NUMBER patients NUMBER NUMBER NUMBER greater equal NUMBER regression NUMBER NUMBER response toxicity ct mild NUMBER patients NUMBER received rt NUMBER NUMBER received ct postoperatively sixteen NUMBER NUMBER alive median duration observation NUMBER months NUMBER NUMBER dead responded preoperative ct NUMBER responders alive disease free mean survival time nonresponders NUMBER months responders NUMBER months longest survivor disease free NUMBER months NUMBER fluorouracil mannitol induced NUMBER week NUMBER NUMBER cgy post ct post ct post sr mg m2 mg m2